Piceatannol

Piceatannol is a stilbene compound found in grapes and red wine that activates the SIRT1 pathway with greater potency than resveratrol. Research suggests it may help regulate blood glucose levels and support fat metabolism through sirtuin activation.

Origin & History

Piceatannol is a naturally occurring stilbenoid polyphenol structurally similar to resveratrol but with an additional hydroxyl group, found primarily in passion fruit seeds, grapes, red wine, white tea, and Japanese knotweed. It is typically extracted from plant materials using solvent extraction and appears as a white-to-yellow solid compound with molecular weight 244.24 g/mol.

Historical & Cultural Context

While piceatannol itself has no prominent traditional use as an isolated compound, its plant sources have historical applications: passion fruit in South American folk medicine for anxiety since the 19th century, and Japanese knotweed (Hu Zhang) in Traditional Chinese Medicine for inflammation since ~100 BCE. The compound occurs in low concentrations naturally and was not traditionally isolated.

Health Benefits

• May reduce postprandial blood glucose by 17.8% based on a small RCT (n=12, PMID: 25694035) - preliminary evidence
• Potentially reduces fat mass and improves adiponectin levels in obese men when combined with exercise (n=20, 8-week trial) - preliminary evidence
• Activates SIRT1 pathway more potently than resveratrol for cellular longevity - preclinical evidence only
• May inhibit inflammatory pathways through NF-κB suppression - primarily in vitro data
• Could support metabolic health via AMPK activation - limited human evidence

How It Works

Piceatannol activates SIRT1 (sirtuin 1) deacetylase enzymes more potently than resveratrol, promoting cellular longevity pathways and metabolic regulation. It enhances glucose uptake through GLUT4 translocation and improves insulin sensitivity via AMPK activation. The compound also modulates adiponectin production and fatty acid oxidation through peroxisome proliferator-activated receptor pathways.

Scientific Research

Human clinical evidence for piceatannol is extremely limited, with only two small RCTs identified: a 2015 study (n=12, PMID: 25694035) showing 100mg reduced glucose response by 17.8%, and a 2018 trial (n=20) using 15mg/day with exercise showing reduced fat mass. No large-scale trials or meta-analyses exist, with most research confined to preclinical models.

Clinical Summary

A small randomized controlled trial (n=12) demonstrated a 17.8% reduction in postprandial blood glucose following piceatannol supplementation, though this represents preliminary evidence requiring larger studies. An 8-week trial in obese men (n=20) combining piceatannol with exercise showed potential improvements in fat mass reduction and adiponectin levels compared to exercise alone. Current human research is limited to small sample sizes and short durations, making definitive clinical recommendations premature.

Nutritional Profile

Piceatannol (3,3',4,5'-tetrahydroxy-trans-stilbene) is a naturally occurring polyphenolic stilbenoid compound with molecular formula C14H12O4 and molecular weight 244.24 g/mol. It is a hydroxylated analog of resveratrol, possessing an additional hydroxyl group at the 3' position on the B-ring, which significantly influences its bioactivity and antioxidant capacity. Primary natural sources include passion fruit (Passiflora edulis) seeds (~2.5–4.8 mg/g dry weight), Japanese knotweed (Polygonum cuspidatum), rhubarb (Rheum rhaponticum), grapes (Vitis vinifera, particularly skin and seeds at ~0.1–0.5 µg/g), berries (blueberries, bilberries in trace amounts), white tea, and certain tree barks (Picea species, from which it derives its name). It also occurs as a metabolite of resveratrol via cytochrome CYP1B1-mediated hydroxylation in vivo. Piceatannol contains no macronutrients (protein, fat, carbohydrate, fiber) as it is a single bioactive compound, not a food matrix. Key bioactive characteristics: ORAC antioxidant capacity significantly exceeds resveratrol (~2–3× greater radical scavenging due to the catechol moiety on the B-ring); acts as a potent Syk tyrosine kinase inhibitor (IC50 ~10 µM); SIRT1 activator with reported EC50 lower than resveratrol; AMPK pathway activator; inhibitor of NF-κB and COX-2 signaling. Bioavailability notes: Oral bioavailability is estimated at <5% in humans, similar to or slightly better than resveratrol, due to extensive phase II metabolism (glucuronidation and sulfation) primarily in the intestine and liver. Major circulating metabolites include piceatannol-3'-O-glucuronide and piceatannol-4'-O-sulfate. The catechol group enhances protein binding but also renders it susceptible to oxidative degradation. Absorption is improved when co-administered with lipid-based carriers or piperine (potential 1.5–2× increase in plasma AUC based on preclinical analogy with resveratrol). Peak plasma concentrations after oral dosing of ~20 mg in humans reach approximately 0.5–2.0 µM transiently (Tmax ~1–2 hours), with rapid clearance (t½ ~1–2 hours). Enterohepatic recirculation may contribute to a secondary plasma peak. Gut microbiota can further metabolize piceatannol to dihydroresveratrol and lunularin, which may retain partial bioactivity. Typical supplemental doses in clinical studies range from 20–40 mg/day, though passion fruit seed extract standardized to piceatannol content (often 5–10% w/w) is more commonly available commercially.

Preparation & Dosage

Clinically studied doses range from 15-100 mg/day oral administration, with 100 mg single dose for acute glucose modulation and 15 mg/day for 8 weeks in obesity trials. Pure powder (>98% purity) or standardized extracts containing 0.1-1% piceatannol from passion fruit seeds are typical forms. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Piperine, Quercetin, Resveratrol, Curcumin, EGCG

Safety & Interactions

Piceatannol appears well-tolerated in short-term studies, with no significant adverse effects reported in available clinical trials. As a stilbene compound similar to resveratrol, it may theoretically interact with anticoagulant medications due to potential effects on platelet function. Safety during pregnancy and lactation has not been established, and the compound should be avoided during these periods. Long-term safety data in humans is currently lacking, warranting caution with extended use.